Streetbeat News

Stock Prices

HNRA

HNR Acquisition has filed a registration statement to register approximately 1.3 million shares that were issued prior to its IPO. This move is aimed at facilitating the approval of its listing with the New York Stock Exchange (NYSE).

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 8:22 pm

MARA

Marathon Digital Holdings Inc (NASDAQ:MARA) shares are trading lower by 6.3% ahead of the company's third-quarter earnings report. The stock may also be falling in sympathy with peer Bitcoin miner Riot Platforms after the company reported worse-than-expected third-quarter financial results. Cryptocurrency-related stocks are known for their high volatility and investors might become more risk-averse and sell off related stocks, such as Marathon Digital Holdings, to limit their exposure to the sector's volatility.

Portfolio Pulse from Henry Khederian

November 08, 2023 | 8:22 pm

LRCX

Deep-pocketed investors have shown a bearish sentiment towards Lam Research (NASDAQ:LRCX), with significant options moves detected. Benzinga's options scanner highlighted 10 extraordinary options activities for Lam Research, with 80% of these investors leaning bearish. The major market movers are focusing on a price band between $475.0 and $700.0 for Lam Research. Analyst ratings for Lam Research include JP Morgan's Overweight rating with a target price of $700, B. Riley Securities' Neutral rating with a target price of $700, and Needham's upgraded rating to Buy with a revised price target of $800.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 8:22 pm

WFC

Financial giants have shown a bearish sentiment towards Wells Fargo (NYSE:WFC) with 83% of traders showing bearish tendencies. Out of 12 unusual trades, 10 were puts, valued at $835,520, and 2 were calls, valued at $75,840. The major market movers are focusing on a price band between $35.0 and $55.0 for Wells Fargo. BMO Capital has maintained their Market Perform rating on Wells Fargo, with a price target of $54.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 8:21 pm

INSP

Inspire Medical Systems Inc (NYSE:INSP) reported Q3 earnings with sales of $153.3 million, up 40% Y/Y, beating the consensus of $154.45 million. The company increased its FY23 revenue guidance to $608 million-$612 million. Mizuho Securities noted a temporary revenue shortfall due to a discontinued pilot program. Despite concerns over potential near-term impacts on its growth trajectory and competition from GLP-1 therapies, analysts view the current dip in share price as an investment opportunity. INSP shares are down 18.90% at $131.20.

Portfolio Pulse from Vandana Singh

November 08, 2023 | 8:21 pm

BLMN

EAT

PLAY

BMO Capital Markets analyst Andrew Strelzik reiterated the Market Perform rating on Bloomin' Brands, Inc. (NASDAQ:BLMN), lowering the price target to $24 from $25. The company reported Q3 FY23 sales growth of 2.3% YoY to $1.079 billion, missing the analyst consensus estimate of $1.085 billion. The analyst remains on the sidelines on BLMN shares due to concerns about the macro environment and potential for a softer spending environment. The analyst also mentioned Brinker International, Inc. (NYSE:EAT) and Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) as preferred near-term opportunities in Restaurants.

Portfolio Pulse from Nabaparna Bhattacharya

November 08, 2023 | 8:18 pm

AMC

AMC Entertainment Holdings, Inc (NYSE:AMC) is expected to report a loss of 38 cents per share on revenues of $1.17 billion for Q3. The company's stock fell over 2% ahead of the earnings announcement. Wedbush maintained a Neutral rating on AMC and lowered the price target from $19 to $11. The firm is optimistic that AMC could post positive guidance for Q4 due to the success of Taylor Swift’s 'Eras Tour Concert' Movie and Beyonce’s upcoming movie release. From a technical analysis perspective, AMC’s stock looks bullish heading into the event.

Portfolio Pulse from Melanie Schaffer

November 08, 2023 | 8:17 pm

BTAI

MRK

BioXcel Therapeutics announced overall survival data from its Phase 2 trial of BXCL701 in combination with Merck's Keytruda in patients with metastatic castration-resistant prostate cancer. The company reported a RECIST partial response rate of 28% with a median duration of response of 19 months. BioXcel is also evaluating strategic options for its subsidiary OnkosXcel Therapeutics, including potential financing, strategic partnership, or M&A. BTAI shares are down 6.78% at $4.51.

Portfolio Pulse from Vandana Singh

November 08, 2023 | 8:15 pm

GLNK

LINKUSD

Grayscale Chainlink Trust (OTCQB:GLNK) is trading at a 200% premium to spot prices, indicating high institutional demand. Each share holds $12 worth of Chainlink’s LINK token, making it almost three times more expensive than the actual value of held assets. The trust holds around $4 million worth of LINK. Rising institutional demand has been pushing crypto token prices higher. Shares of GLNK were up 35% on Wednesday to $52.95, while LINK is up 10.7% in the past 24 hours.

Portfolio Pulse from Khyathi Dalal

November 08, 2023 | 8:09 pm

AMZN

WBD

Warner Bros. Discovery (NASDAQ:WBD) shares fell after Q3 financial results showed a 2% YoY revenue increase to $9.98 billion, but a loss of 700,000 streaming subscribers. The company plans to leverage its 'underused' franchises, including a reboot of the 'Harry Potter' series, to boost future success. However, the new show may not be available until 2025 or 2026. The company is also working on a rebranding of DC Comics and a new slate of movies and TV shows.

Portfolio Pulse from Chris Katje

November 08, 2023 | 8:06 pm